QSAR analysis and molecular modeling of ABCG2-specific inhibitors

In addition to its critical role is controlling drug availability and protecting sensitive organs and stem cells through cellular detoxification. breast cancer resistance protein (BCRP/ABCG2) plays an important role in cancer cell resistance to chemotherapy, together with P-glycoprotein/ABCB1. A main approach to abolish multidrug resistance is to find out specific inhibitors of the drug-efflux activity, able to chemosensitize cancer cell proliferation. Many efforts have been primarily focused on ABCB1, discovered thirty years ago, whereas very few studies have concerned ABCG2, identified much more recently. This review describes the main types of inhibitors presently known for ABCG2, and how quantitative structure-activity relationship analysis among series of compounds may lead to build up molecular models and pharmacophores allowing to design lead inhibitors as future candidates for clinical trials. A special attention is drawn on flavonoids which constitute a structural ly-diverse class of compounds, well suited to identify potent ABCG2-specific inhibitors. (C) 2008 Elsevier B.V. All rights reserved.